Jeffrey M Wilson1, Alexander J Schuyler1, Lisa Workman1, Monica Gupta1, Hayley R James1, Jonathon Posthumus2, Emily C McGowan1, Scott P Commins3, Thomas A E Platts-Mills4. 1. Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville, Va. 2. Allergy Partners of Fredericksburg, Fredericksburg, Va. 3. Division of Rheumatology, Allergy and Immunology, University of North Carolina, Chapel Hill, NC. Electronic address: scommins@email.unc.edu. 4. Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville, Va. Electronic address: tap2z@virginia.edu.
Abstract
BACKGROUND: Red meat allergy has historically been understood as a rare disease of atopic children, but the discovery of the "α-Gal syndrome," which relates to IgE to the oligosaccharide galactose-α-1,3-galactose (α-Gal), has challenged that notion. OBJECTIVE: To describe the clinical and immunologic characteristics of a large group of subjects with self-reported allergy to mammalian meat. METHODS: This was an observational study of 261 children and adults (range, 5-82 years) who presented for evaluation for allergic reactions to mammalian meat. Results were based on serum assays and a detailed questionnaire. RESULTS: α-Gal specific IgE ≥ 0.35 IU/mL was detected in 245 subjects and symptom onset occurred ≥2 hours after eating mammalian meat in 211 (81%). Component testing supported a diagnosis of α-Gal syndrome in 95%, pork-cat syndrome in 1.9%, and primary beef allergy in 1.1%. Urticaria was reported by 93%, anaphylaxis by 60%, and gastrointestinal symptoms by 64%. Levels of IgE and IgG specific to α-Gal were similar in subjects who reported early- or delayed-onset symptoms, and in those with and without anaphylaxis. Levels of α-Gal specific IgE and severity of reactions were similar among those with and without traditional atopy, and among children (n = 35) and adults (n = 226). Blood group B trended toward being under-represented among α-Gal-sensitized subjects; however, α-Gal specific IgE titers were high in symptomatic cases with B-antigen. CONCLUSIONS: The α-Gal syndrome is a regionally common form of food allergy that has a characteristic but not universal delay in symptom onset, includes gastrointestinal symptoms, can develop at any time in life, and is equally common in otherwise nonatopic individuals.
BACKGROUND: Red meat allergy has historically been understood as a rare disease of atopic children, but the discovery of the "α-Gal syndrome," which relates to IgE to the oligosaccharidegalactose-α-1,3-galactose (α-Gal), has challenged that notion. OBJECTIVE: To describe the clinical and immunologic characteristics of a large group of subjects with self-reported allergy to mammalian meat. METHODS: This was an observational study of 261 children and adults (range, 5-82 years) who presented for evaluation for allergic reactions to mammalian meat. Results were based on serum assays and a detailed questionnaire. RESULTS: α-Gal specific IgE ≥ 0.35 IU/mL was detected in 245 subjects and symptom onset occurred ≥2 hours after eating mammalian meat in 211 (81%). Component testing supported a diagnosis of α-Gal syndrome in 95%, pork-cat syndrome in 1.9%, and primary beef allergy in 1.1%. Urticaria was reported by 93%, anaphylaxis by 60%, and gastrointestinal symptoms by 64%. Levels of IgE and IgG specific to α-Gal were similar in subjects who reported early- or delayed-onset symptoms, and in those with and without anaphylaxis. Levels of α-Gal specific IgE and severity of reactions were similar among those with and without traditional atopy, and among children (n = 35) and adults (n = 226). Blood group B trended toward being under-represented among α-Gal-sensitized subjects; however, α-Gal specific IgE titers were high in symptomatic cases with B-antigen. CONCLUSIONS: The α-Gal syndrome is a regionally common form of food allergy that has a characteristic but not universal delay in symptom onset, includes gastrointestinal symptoms, can develop at any time in life, and is equally common in otherwise nonatopic individuals.
Authors: Jan Kotál; Helena Langhansová; Jaroslava Lieskovská; John F Andersen; Ivo M B Francischetti; Triantafyllos Chavakis; Jan Kopecký; Joao H F Pedra; Michail Kotsyfakis; Jindřich Chmelař Journal: J Proteomics Date: 2015-07-17 Impact factor: 4.044
Authors: Maya K C Retterer; Lisa J Workman; John R Bacon; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2018-02-01 Impact factor: 10.793
Authors: Scott P Commins; Shama M Satinover; Jacob Hosen; Jonathan Mozena; Larry Borish; Barrett D Lewis; Judith A Woodfolk; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2008-12-13 Impact factor: 10.793
Authors: Thomas A E Platts-Mills; Scott P Commins; Tilo Biedermann; Marianne van Hage; Michael Levin; Lisa A Beck; Maria Diuk-Wasser; Uta Jappe; Danijela Apostolovic; Michael Minnicozzi; Marshall Plaut; Jeffrey M Wilson Journal: J Allergy Clin Immunol Date: 2020-02-10 Impact factor: 10.793
Authors: Margaret Shin Kim; Matthew D Straesser; Behnam Keshavarz; Lisa Workman; Emily C McGowan; Thomas A E Platts-Mills; Jeffrey M Wilson Journal: J Allergy Clin Immunol Pract Date: 2019-09-11
Authors: Jeffrey M Wilson; Behnam Keshavarz; Hayley R James; Maya K C Retterer; Alexander J Schuyler; Alice Knoedler; Lisa J Workman; Lucy Ng'ang'a; Martha E Chico; Eva Rönmark; Peter W Heymann; Matthew S Perzanowski; Thomas A E Platts-Mills; Philip J Cooper Journal: J Allergy Clin Immunol Date: 2021-02-01 Impact factor: 10.793
Authors: Jeffrey M Wilson; Behnam Keshavarz; Maya Retterer; Lisa J Workman; Alexander J Schuyler; Emily C McGowan; Charles Lane; Alaaddin Kandeel; Jane Purser; Eva Rönmark; Joseph LaRussa; Scott P Commins; Tina Merritt; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2020-06-06 Impact factor: 10.793
Authors: Matthew Straesser; Behnam Keshavarz; Larry Borish; Dilawar Khokhar; Angela Holian; Nathan P Charlton; Thomas A E Platts-Mills; Jeffrey M Wilson Journal: J Allergy Clin Immunol Pract Date: 2020-10-27